Want to join the conversation?
Bio-pharmaceutical company $AMGN said that $CVS, a healthcare company, will provide access to Repatha, a cholesterol-lowering drug to its patients under CVS/caremark commercial formularies. $AMGN is also providing RepathaReady program, a suite of services to help patients & providers with free Repatha when insurance coverage is pending.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?